Introduction: Atrial dilation and left ventricular hypertrophy in hypertensive patients are known predictive factors for cardiovascular disease. We investigated whether stratification of the cardiovascular events onset was possible from echocardiographic parameters in patients with hypertension.
Subjects and methods: The subjects were 357 consecutive patients with hypertension receiving drug therapy and were aged from their 20’s through their 80’s (mean age: 64.7±13.4 years, males/females: 194/163) who had undergone echocardiographic examination. Patients with atrial fibrillation, ischemic heart disease, and more-than-moderate mitral valve regurgitation, as well as hypertensive patients in whom it was difficult to perform follow-up examinations, were excluded. The relation between the patients’ clinical characteristics, echocardiographic parameters, and incidence of cardiovascular events (heart failure, acute coronary syndrome, and stroke) were investigated.
Results: Events occurred in 24 cases (11 cases of heart failure, 5 cases of acute coronary syndrome, and 8 cases of stroke) while we were observing patient progress after echocardiography (average: 821±443 days). The subjects were divided into 2 groups depending upon whether or not an event had occurred. A multivariate analysis with an explanatory variable for items for which a univariate analysis using logistic regression analysis had shown a significant difference, showed that left atrial volume index (LAVI) and left ventricular mass index (LVMI) were predictive factors for occurrence of cardiovascular events [LAVI: Odds Ratio (OR) 1.07, p=0.003, LVMI: OR 1.02, p=0.007]. LAVI and LVMI were divided into 4 grades (normal, mild, moderate, and severe) and scored from 0 to 3 points. The LALV index was defined as the total LAVI and LVMI scores of all subjects. When a survival analysis was conducted according to the Kaplan-Meier method, the incidence of cardiovascular events was significantly higher (Log-rank, p〈0.0001) when the LALV index was higher.
Conclusion: Our results suggest that quantitative evaluation using both LAVI and LVMI indices is a useful method for predicting occurrence of cardiovascular events in patients receiving hypertension therapy.
View full abstract